跳至主要内容
临床试验/EUCTR2005-000967-24-DE
EUCTR2005-000967-24-DE进行中(未招募)1 期

Evaluation of Response Rate to Pre-operative Docetaxel + Herceptin study part A and Docetaxel study part B In Locally Advanced Breast Cancer Patients, Stratified by HER2-Status, Trial Phase II - HEDO

Technical University of Munich0 个研究点目标入组 94 人开始时间: 2005年8月30日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
94

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Female

入选标准

  • •locally advanced breast cancer histol. proof
  • •primary tumor >= 2cm
  • •Are the trial subjects under 18? no
  • •Number of subjects for this age range:
  • •F.1.2 Adults (18-64 years) yes
  • •F.1.2.1 Number of subjects for this age range
  • •F.1.3 Elderly (>=65 years) no
  • •F.1.3.1 Number of subjects for this age range

排除标准

  • •evidence of distant metastases by clinical diagnosis
  • •multifocal primary tumor, defined as histologically confirmed tumor-manifestations within different quadrants;
  • •distance = 4 cm
  • •pre-existing motor or sensory neuropathy of a severity = grade 2 NCI criteria
  • •previous breast cancer
  • •inflammatory breast cancer without bi-dimensional measure lesion
  • •prior systemic therapy for cancer
  • •previous therapy with Herceptin
  • •patients with immunosuppressive therapy
  • •invasive malignancy which could affect compliance with the protocol or interpretation of results.
  • •Patients who have been curatively treated and have been free of malignant disease for greater than 5 years are generally eligible.
  • •Inadequate bone marrow, hepatic and renal functions as evidence by the following:
  • •neutrophil count of < 1500 platelet count of < 100,000/µL, Haemoglobin < 10g/dL; serum total bilirubin > 1.0 x ULN GBG (except for patients with clearly documented Gilbert's syndrome), ALT or AST > 1.5 x ULN
  • •alkaline phosphate > 2,5 x ULN, serum creatinine > 1,5 x ULN
  • •concurrent treatment with any other anti-cancer therapy
  • •known hypersensitivity reaction to the compounds or incorporated substances

研究者

发起方
Technical University of Munich

相似试验